The history of the neurologic examination, referral pattern among neurologists for neurointerventional procedures, Parkinson's disease on the Internet, and online learning are just a few of the many topics discussed during the Day 2 sessions at the AAN meeting.
Alternating mammography and MRI every 6 months appears to be the best way to detect cancer in high-risk women, an M.D. Anderson study found. This strategy can identify cancers not found by mammography alone, said Huong Le-Petross, MD, assistant professor, Diagnostic Radiology, who presented a retrospective pilot study at a poster session during the San Antonio Breast Cancer Symposium.
Tamoxifen, long considered the gold standard for treating estrogen-receptor (ER) positive, early-stage breast cancer, is known to increase the risk of thrombotic events (blood clots).
Researchers have released findings from a large retrospective study showing that women treated for early stage HER2-positive breast cancer tumors ≤ 1cm have a significantly greater risk of recurrence than women whose tumors are HER2-negative.
When physicians first realize they are being sued for malpractice, they feel %u201Cshame, anger, depression, a loss of control, and a crisis of confidence."
A study reveals a beneficial effect of tamoxifen on breast cancer recurrences at 10 and 15 years of follow-up in women with ductal carcinoma in situ (DCIS).
Updates to the NCCN Prostate Cancer Guidelines were presented by James L. Mohler, MD.